مباشر

CellB cell deficiency limits exercise capacity by remodeling liver glutamate metabolism CellA phytoscreen identifies a garlic compound as a deterrent of mating and egg laying in <em>Drosophila</em> and mosquitoes Cellp53 safeguards chemical reprogramming of human somatic cells toward pluripotency Cell2'3'-cGAMP-induced membrane shearing promotes broad antiphage immunity CellGut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockade FierceBiotechAACR: Endeavoring to go global, Zai Lab offers reality check on China’s biotech ascent NVIDIAGoogle developing inference AI chips to rival Nvidia - qz.com CorningSpring book sale returns to benefit Southeast Steuben County Library - WETM BioPharma DiveRFK Jr. defends HHS tenure, 12% proposed budget cut Insilico MedicineInsilico Medicine Highlights AI Benchmarking Platform for Drug Discovery - TipRanks BDBD Wong to Star in Solo Performance of The Glass Menagerie for Philadelphia Theatre Company - TheaterMania IlluminaTsinghua University brings hands-on multiomics training to young scientists - Illumina

Endpoints News ٢١ نوفمبر ٢٠٢٥

Sarepta ends Elevidys trial with Hansa's pre-treatment; Some pipeline cuts at Moderna

Plus, news about Blue Lake, Bambusa, Inhibikase Therapeutics and Olema Oncology: 🛑 Sarepta terminates Elevidys trial with Hansa Biopharma’s imlifidase: The stu...

Plus, news about Blue Lake, Bambusa, Inhibikase Therapeutics and Olema Oncology: 🛑 Sarepta terminates Elevidys trial with Hansa Biopharma’s imlifidase: The study was examining whether Hansa’s imlifidase, an IgG antibody-cleaving enzyme, could help reduce ...